Anti-vascular endothelial growth factor (anti-VEGF) drugs for diabetic macular oedema

Diabetic macular oedema is a common complication of diabetes, in which damage to the blood vessels at the back of the eye leads to swelling. Lucentis, Eylea and Avastin are three antiangiogenic drugs that can be injected into the eye to treat the blood vessels and reduce the swelling. In June 2017, Gianni Virgili from the University of Florence in Italy, and colleagues, updated their Cochrane Review of these drugs and used a network meta-analysis to compare their effects.
Source: Podcasts from The Cochrane Library - Category: General Medicine Authors: Source Type: podcasts